ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI. ORLYNVAH™ possesses potent activity against species of Enterobacterales including those that encode extended spectrum ...

E. coli infections, affecting millions globally, arise from strains of the bacterium Escherichia coli. While most E. coli are ...

Some antibiotics can cause a yeast infection. Learn more about how antibiotics cause yeast infections, risk factors for yeast ...

Iterum Therapeutics ( (ITRM) ) has released its Q3 earnings. Here is a breakdown of the information Iterum Therapeutics presented to its ...

A WOMAN who was admitted to hospital with a UTI died after contracting a dangerous ... she had proved resistant to all available antibiotics, and after 24 hours of being hospitalised, she died.

New diagnostic criteria [3] Urinary tract infection (UTI ... the difficulty to obtain such a sample in young children. Oral antibiotics seem to be efficacious in most cases, but hospitalization ...

Replacing intravenous antibiotics with effective oral antibiotics in the treatment of serious infections (community-acquired pneumonia, nosocomial pneumonia, and urinary tract infections ...

This refers to a debilitating infection that does not subside, that fails to respond to short-term antibiotics and that does not show up on urine tests. Chronic UTI patients often spend up to £45 ...

Opens in a new tab or window For children with a history of recurrent urinary tract infection (RUTI), the antibiotic nitrofurantoin and cranberry products appeared to decrease the incidence of ...

Clinical question: Is there a mortality difference between early transition to oral antibiotics versus prolonged intravenous antibiotics in uncomplicated gram-negative bacteremia? Background: Although ...

coli reduction in uncomplicated UTIs, with promising results in the phase 2 trial. The study involved 39 patients, with different dosing regimens, and observed rapid E. coli reduction and symptom ...